APA (7th ed.) Citation

Hutson, P. H., Tarazi, F. I., Madhoo, M., Slawecki, C., & Patkar, A. A. (2014). Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders. Pharmacology & therapeutics (Oxford), 143(3), 253-264. https://doi.org/10.1016/j.pharmthera.2014.03.005

Chicago Style (17th ed.) Citation

Hutson, Peter H., Frank I. Tarazi, Manisha Madhoo, Craig Slawecki, and Ashwin A. Patkar. "Preclinical Pharmacology of Amphetamine: Implications for the Treatment of Neuropsychiatric Disorders." Pharmacology & Therapeutics (Oxford) 143, no. 3 (2014): 253-264. https://doi.org/10.1016/j.pharmthera.2014.03.005.

MLA (9th ed.) Citation

Hutson, Peter H., et al. "Preclinical Pharmacology of Amphetamine: Implications for the Treatment of Neuropsychiatric Disorders." Pharmacology & Therapeutics (Oxford), vol. 143, no. 3, 2014, pp. 253-264, https://doi.org/10.1016/j.pharmthera.2014.03.005.